WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ) announced today that the company’s first generation, integrated point-of-care (POC) cell therapy manufacturing system demonstrated ...
The biopharmaceutical industry is undergoing a structural shift. For decades, contract development and manufacturing organisations (CDMOs) have operated through fragmented models, with drug substance ...
Although estimates vary slightly, many industry experts predict continuous manufacturing will, at the least, cut the cost of manufacturing biologics in half. Thus, it will be an attractive option for ...
Pharmaceutical manufacturing steps are often isolated in space and time. The synthesis, isolation and purification of the drug substance (DS) and the formulation of the drug product (DP) may be ...
13d
Advancing Industrial Precision: The Evolution of Machine Vision Solutions in Global Manufacturing
The landscape of global manufacturing is undergoing a profound transformation. As industries move toward higher levels of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback